ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2026-3401

A weakness has been identified in SourceCodester Web-based Pharmacy Product Management System 1.0.

Published Mar 2, 2026 · catalog updated Jun 17, 2026 · web-based pharmacy product management system

Check if you run it

No confirmed exploitation is on record for CVE-2026-3401. EPSS is 0.51%. Act only if a listed version of web-based pharmacy product management system is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Low1.3
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.51%
Remediation
Advisory link
Affected products
cpe senior-walter/web-based pharmacy product management system

A weakness has been identified in SourceCodester Web-based Pharmacy Product Management System 1.0. This affects an unknown part. This manipulation causes session expiration. Remote exploitation of the attack is possible. The complexity of an attack is rather high. It is indicated that the exploitability is difficult. The exploit has been made available to the public and could be used for attacks.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe senior-walter/web-based pharmacy product management system1.0

How to fix CVE-2026-3401

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-3401. EPSS is 0.51%. Act only if a listed version of web-based pharmacy product management system is installed.

Which versions are affected?

Compare what you have installed with senior-walter/web-based pharmacy product management system 1.0. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-613: Insufficient Session Expiration. EPSS 0.51%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Mar 2, 2026 · NIST NVD

    Detected

    A weakness has been identified in SourceCodester Web-based Pharmacy Product Management System 1.0. This affects an unknown part. This manipulation causes session expiration. Remote exploitation of the attack is possible. The complexity of an attack is rather high. It is indicated that the exploitability is difficult. The exploit has been made available to the public and could be used for attacks.

  2. Jun 17, 2026 · NIST NVD

    Updated

    A weakness has been identified in SourceCodester Web-based Pharmacy Product Management System 1.0. This affects an unknown part. This manipulation causes session expiration. Remote exploitation of the attack is possible. The complexity of an attack is rather high. It is indicated that the exploitability is difficult. The exploit has been made available to the public and could be used for attacks.

Sources

  • CVE.orgVulnerability recordCVE-2026-3401

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-3401

    30-day exploitation probability 0.5%

    first.org
  • NIST NVDVulnerability recordCVE-2026-3401

    A weakness has been identified in SourceCodester Web-based Pharmacy Product Management System 1.0. This affects an unknown part. This manipulation causes session expiration. Remote exploitation of the attack is possible. The complexity of an attack is rather high. It is indicated

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.